Denver (CO), 23 jun (EFE News).- A national study conducted by experts from the University of Colorado in Denver revealed that not only the police but also the medicine discriminates against african-americans and hispanics, specifically against lung cancer patients who do not receive the same diagnoses than white patients.
The study, released Tuesday by the University of Colorado in its public version and abbreviated, had been previously published in the specialized magazine Journal of the National Cancer Institute.
According to dr. Rustain L. Morgan, in charge of the investigations, “the african-american patients and hispanics were less likely to have to diagnosticarles non-small cell cancer in his lungs, they use the technology of imaging recommended”.
Morgan and his colleagues came to this conclusion after analyzing the database of Medicare (the public health programme of the federal Government of the united States) between 2007 to 2015 for comparison, “the initial type of imaging technology” that received patients with lung cancer according to their ethnicity or race.
The research included data from nearly 29,000 white patients, with over 3,100 african-american patients and a little less than 2,000 hispanics, all of them older than 66 years.
The result was that, when you adjust the numbers according to various factors (demography, community, type of hospital), patients from minority groups were significantly less likely than whites to be diagnosed by means of positron emission tomography (PET in English), one of the forms of computed tomography.
That discrepancy, “explains in part the differences in survival between white patients and non-white.
Specifically, “if the patients are african american and hispanic do not receive the best technology of images, that can be one of the pieces of the puzzle to explain why these patients with lung cancer tend to have worse outcomes than white patients” Morgan said in prepared remarks.
And that happens despite the fact that it is known that the computed tomography PET “is associated with a better survival.”
Already in may of 2019, in another study based on data from 2006 to 2011, Morgan and his colleagues had observed a similar situation among patients affected by cancer in the mouth or in the throat.
That report concluded that the patients who were examined with PET “had a higher level of survival than those who only were examined with computed tomography or with magnetic resonance imaging (MRI)”.
At the conclusion of the new research, Morgan asserted that “awareness of this issue will allow future interventions to reduce this gap”.
(c) Agencia EFE